L3VLUP
ProSign in

INNV · CI in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

INNVCI
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • INNV
  • CI
010203040202120222023202420252026
Holders and value by quarter
QuarterINNVCI
Q3 2020none listed holders, n.a.34 holders, $18.1bn
Q4 2020none listed holders, n.a.22 holders, $21.9bn
Q1 20218 holders, $74m24 holders, $23.9bn
Q2 20213 holders, $46m31 holders, $22.5bn
Q3 20212 holders, $13m30 holders, $17.8bn
Q4 20211 holders, $5.6m26 holders, $20.1bn
Q1 20221 holders, $6.6m28 holders, $20.4bn
Q2 20221 holders, $3.8m32 holders, $22.1bn
Q3 2022none listed holders, n.a.31 holders, $21.5bn
Q4 2022none listed holders, n.a.30 holders, $24.7bn
Q1 2023none listed holders, n.a.35 holders, $18.2bn
Q2 2023none listed holders, n.a.30 holders, $19.8bn
Q3 2023none listed holders, n.a.28 holders, $19.8bn
Q4 2023none listed holders, n.a.31 holders, $20.6bn
Q1 2024none listed holders, n.a.28 holders, $24.0bn
Q2 2024none listed holders, n.a.28 holders, $19.5bn
Q3 2024none listed holders, n.a.25 holders, $20.2bn
Q4 2024none listed holders, n.a.23 holders, $15.2bn
Q1 2025none listed holders, n.a.24 holders, $18.4bn
Q2 2025none listed holders, n.a.34 holders, $19.5bn
Q3 2025none listed holders, n.a.28 holders, $16.2bn
Q4 2025none listed holders, n.a.21 holders, $14.6bn
Q1 2026none listed holders, n.a.26 holders, $13.5bn
Q2 2026none listed holders, n.a.28 holders, $13.0bn
INNV

Innovage HLDG Corp

Holders
0
Reported value
$0
Buyers
n.a.
Sellers
n.a.

No cross-section for this quarter.

Health care services and research
CI

The Cigna Group

Holders
31
Reported value
$20.6bn
Buyers
16
Sellers
19

Breadth -3 among 93 comparable managers.

Health care services and researchManaged care

Who holds both, Q4 2023

Among the 31 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only INNV (0)

None.

Only CI (31)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Glenview Capital Management LLC, Invesco Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Soros Fund Management LLC, Squarepoint Ops LLC, and 6 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →